Mohammad Mahdi Parvizi

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 18

Top Venues

Dermatologic therapy

Journal of cosmetic dermatology

International journal of clinical practice

BMC complementary medicine and therapies

Molecular Dermatology Research Center, Shiraz University of Medical Sciences

Shiraz University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Molecular Dermatology Research Center, Shiraz University of Medical Sciences Oct 25 2017

Iran

Assistant Professor, Researcher :: Molecular Dermatology Research Center

Shiraz University of Medical Sciences, Vice Chancellor of Treatment Jan 26 2012 - Oct 23 2017

Iran

Medical Doctor, Case Manager :: Medical Care Monitoring Center (MCMC)

Education History

Shiraz University of Medical Sciences Feb 03 2013 - Oct 24 2017

Iran

PHD

Shiraz University of Medical Sciences Feb 04 2014 - Oct 03 2016

Iran

MSC

Shiraz University of Medical Sciences Oct 07 2011 - Dec 20 2015

Iran

MSC

Publications

Mohammad Mahdi Parvizi, Nasrin Saki, Soodabeh Samimi, Roya Radanfer, Mohammad Miaad Shahrizi, Mohammad Mehdi Zarshenas
Efficacy of castor oil cream in treating infraorbital hyperpigmentation: An exploratory single-arm clinical trial. Journal of cosmetic dermatology (2023)
Maryam Sadat Sadati, Nazafarin Yazdanpanah, Reza Shahriarirad, Rojan Javaheri, Mohammad Mahdi Parvizi
Efficacy of metformin vs. doxycycline in treating acne vulgaris: An assessor-blinded, add-on, randomized, controlled clinical trial. Journal of cosmetic dermatology (2023)
Nasrin Saki, Samira Vahedi, Mohammad Mahdi Parvizi, Mohammad Shafie'ei, Seyed Ali Hosseini, Najmeh Ahramiyanpour
Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: A pilot, double-blind, split-site, randomized controlled trial. Dermatologic therapy 35 (10) (2022)
Mohammad Mahdi Parvizi, Sedigheh Forouhari, Reza Shahriarirad, Sepehr Shahriarirad, Ryan D Bradley, Leila Roosta
Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19. BMC complementary medicine and therapies 22 (1) (2022)
Mohammad Mahdi Parvizi, Mohammad Hossein Salami, Arezoo Moini Jazani, Rojan Javaheri, Amir Mohammad Jaladat, Farhad Handjani
Complementary and integrative remedies in the treatment of chronic pruritus: A review of clinical trials. Journal of cosmetic dermatology (2022)
Nazanin Zahra Sepehri, Mohammad Mahdi Parvizi, Sepideh Habibzadeh, Farhad Handjani
Lettuce as an Effective Remedy in Uremic Pruritus: Review of the Literature Supplemented by an In Silico Study. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Mehdi Pasalar, Fatemeh Tabatabaei, Ryan Bradley, Haleh Tajadini, Mohadese Kamali, Fatemeh Sadat Hasheminasab, Mohammad Mahdi Parvizi
Mechanistic support of traditional Persian medicine for the treatment of acne vulgaris: A scoping review. Journal of cosmetic dermatology (2021)
Camellia Torabizadeh, Sara Rousta, Sakineh Gholamzadeh, Javad Kojouri, Kavoos Jamali, Mohammad Mahdi Parvizi
Efficacy of education delivery through multimedia and text messaging on the psychological parameters of patients scheduled for coronary angiography: a single-blind randomized controlled clinical trial. BMC cardiovascular disorders 21 (1) (2021)
Mohammad Mahdi Parvizi, Nazanin Fatehi, Amir Mohammad Jaladat, Zahra Gholampour, Reza Shahriarirad, Amirhossein Erfani
Epidemiological factors in patients with dermatologic conditions referring to the clinic of traditional Persian Medicine: A cross-sectional study. International journal of clinical practice 75 (11) (2021)
Mehdi Ghahartars, Seyed Ali Hossein Zahraei, Fatemeh Sari Aslani, Maryam Hadibarhaghtalab, Mohammad Mahdi Parvizi
A 58-year-old man with porokeratosis ptychotropica: A successful treatment with alone cryotherapy and literature review. Dermatologic therapy 34 (1) (2021)
Mehdi Pasalar, Zahra Bagheri, Amin Hojati-Moghadam, Arndt Büssing, Mohammad Mahdi Parvizi
Psychometric Properties of a Persian Version of the SpREUK-P Questionnaire: An Instrument for Measuring the Importance and Frequency of Spiritual/Religious Practices in Iranian Patients with Chronic Gastrointestinal Diseases. Journal of religion and health (2021)
Soheila Alyasin, Seyed Hesamedin Nabavizadeh, Hossein Esmaeilzadeh, Seyed Taghi Heydari, Seyed Hamdollah Mosavat, Mohammad Mahdi Parvizi, Seyyed Mohammad Hashemi, Mohammad Hashem Hashempur
Efficacy of oral supplementation of whey protein in patients with contact dermatitis: A pilot randomized double-blind placebo-controlled clinical trial. Dermatologic therapy 33 (6) (2020)
Farideh Jowkar, Motahhareh Hosseini Kahnooj, Fatemeh Sari Aslani, Mohammad Mahdi Parvizi
Clinicopathological evaluation of patients with rippled pattern pigmentation of the skin: A single-center study. Dermatologic therapy 33 (3) (2020)
Farzaneh Zare, Mohammad Mahdi Parvizi, Nasrin Saki, Amir Mohammad Jaladat
Applications of Ma'aljobon, a natural remedy from traditional Persian medicine, in dermatology: A journey from past to modernity. Dermatologic therapy 33 (6) (2020)
Mehdi Ghahartars, Maryam Ahmadyan, Maryam Salimkhanian, Somayeh Yazdanpanah, Mohammad Mahdi Parvizi, Kamiar Zomorodian
Levels of zinc and vitamin D3 in patients with pityriasis versicolor:A study in Southern Iran, Shiraz. Dermatologic therapy 33 (6) (2020)
Nasrin Saki, Najmeh Ahramiyanpour, Alireza Heiran, Shohreh Alipour, Mohammad Mahdi Parvizi
Efficacy of topical dimethyl sulfoxide (DMSO) 50% solution vs tretinoin 0.5% cream in treatment of patients with primary macular amyloidosis: A split-side single-blinded randomized clinical trial. Dermatologic therapy 33 (3) (2020)
Mohammad Mahdi Parvizi, Farzaneh Zare, Farhad Handjani, Majid Nimrouzi, Mohammad M Zarshenas
Overview of herbal and traditional remedies in the treatment of cutaneous leishmaniasis based on Traditional Persian Medicine. Dermatologic therapy 33 (4) (2020)
Farideh Jowkar, Hamid Godarzi, Mohammad Mahdi Parvizi
Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone. The Journal of dermatological treatment 31 (3) (2019)

Mohammad Mahdi Parvizi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammad Mahdi Parvizi